<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作為您在 Google 上的首選新聞來源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>總統唐納德·特朗普簽署了一項行政命令，將加速嚴重心理疾病患者的治療獲取，重申了他對推進為遭受毀滅性、複雜且難以治療的疾病的美國人提供希望的解決方案的承諾。</p>
<p>該命令指示食品和藥物管理局局長向符合國家優先券計劃標準的、已獲得突破性療法認證的適當迷幻藥提供局長國家優先券。這將確保繁瑣的程序不會延遲 FDA 對任何潛在療法的黃金標準審查。</p>
<p>本文是我們優質內容的一部分。請通過 RTTNews 訂閲進行訂閲。</p>
<p>立即訂閲</p>
<p>已經訂閲？登錄</p>
<p>如有意見和反饋，請聯繫：editorial@rttnews.com</p>
<p>商業新聞</p>

CMPS

MNMD

PSIL

<p>總統唐納德·特朗普簽署了一項行政命令，以加快對嚴重心理疾病治療的獲取。該命令指示 FDA 為具有突破性療法認證的迷幻藥提供國家優先券，確保及時審查並減少複雜病症患者獲得治療的延遲</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作為您在 Google 上的首選新聞來源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>President Donald Trump has signed an Executive Order that will accelerate access to treatments for patients with serious mental illness, reaffirming his commitment to advancing solutions that provide hope to Americans with devastating, complex, and treatment-resistant conditions.</p>
<div class="lb-trans"><p>總統唐納德·特朗普簽署了一項行政命令，將加速嚴重心理疾病患者的治療獲取，重申了他對推進為遭受毀滅性、複雜且難以治療的疾病的美國人提供希望的解決方案的承諾。</p>
</div><p>The Order directs the Food and Drug Administration Commissioner to provide Commissioner's National Priority Vouchers to appropriate psychedelic drugs that have received Breakthrough Therapy designations for treating serious mental illnesses, and that meet the criteria of the National Priority Voucher Program. This will ensure that red tape does not delay the FDA's gold standard review of any potential therapy.</p>
<div class="lb-trans"><p>該命令指示食品和藥物管理局局長向符合國家優先券計劃標準的、已獲得突破性療法認證的適當迷幻藥提供局長國家優先券。這將確保繁瑣的程序不會延遲 FDA 對任何潛在療法的黃金標準審查。</p>
</div><p>This article is part of our premium content offering.Subscribe with a RTTNews subscription.</p>
<div class="lb-trans"><p>本文是我們優質內容的一部分。請通過 RTTNews 訂閲進行訂閲。</p>
</div><p>Subscribe Now</p>
<div class="lb-trans"><p>立即訂閲</p>
</div><p>Already subscribed? Sign in</p>
<div class="lb-trans"><p>已經訂閲？登錄</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意見和反饋，請聯繫：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商業新聞</p>
</div>

特朗普下令加速嚴重精神疾病的治療進程